
BCAL and ClearNote partner to bring early cancer detection blood tests to Australia
The agreement provides BCAL with rights to distribute and commercialise the tests in Australia and New Zealand and covers all future tests based on ClearNote Health’s proprietary epigenomics testing platform. BCAL will leverage its existing partnership …